Question · asked by 1 review
Intratympanic corticosteroids vs no treatment or versus placebo: Persistent tympanic membrane perforation
- Population
- sudden sensorineural hearing loss
- Intervention
- Intratympanic corticosteroids
- Comparison
- no treatment or versus placebo
- Outcome
- Persistent tympanic membrane perforation
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Intratympanic corticosteroids vs no treatment or versus placebo Persistent tympanic membrane perforation · sudden sensorineural hearing loss Intratympanic corticosteroids for sudden sensorineural hearing loss (2022) · Cochrane Headline outcomes only | no estimate extracted | 5 studies · 185 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Intratympanic corticosteroids for sudden sensorineural hearing loss 2022 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.